| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Simple Pay Plans Can Make Sales Explode! |
|
Advice You - Simple Pay Plans Can Make Sales Explode!
I just finished reading an article by Jack Trout at Forbes.com. He is the pioneer of the concept of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product “positioning,” and author of at least a few books. Recently, he discovered a book dating back to aro ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in und 1916 that offers certain business secrets, and one of them boils down to seeking simplicity in yo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ur sales and marketing program. If your approach is too clever, as Peter F. Drucker once characteriz here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ed many modern contrivances, it is bound to fail. One of the points Trout gets from the old tome, “O d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro vious Adams,” is that an idea upon being heard should “explode” in the listener’s mind. He should ask ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc , “Why didn’t we think of that, before?” Last week, I conducted a new seminar in Sao Paulo, Brazil. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi My audience consisted of about one hundred sales managers, directors, and business owners, and we cov nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ered in depth the topic of motivating and compensating sellers. I reviewed five different psychologi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ es and then tied them into typical compensation formulas. This is good stuff. But then, I unveiled a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi pay plan that in my experience is the very best one of all. It keeps top sellers’s noses happily to t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a he grindstone and it produces overall equity. Someone who sells three times more will earn triple wh dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod at his peer earns. But this isn’t a harsh commission-only plan. Anyway, it is very simple. I asked cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin everyone in the room if THEY would like to be paid this way. Nearly all would, and would their salesp tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen eople like it and perform well under it? Yes, again, was the answer. But how many of them felt they t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel could recommend it and have it be adopted? Very few hands went up. Why? The plan seems “too rich” ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust one of them pointed out. It’s “too good” another one said. I think what they were really saying is it y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ’s too obvious and too simple! Of course, I took these remarks and concerns as an opportunity to pit . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ch my on site consulting. My life is all about introducing change into organizations, and whenever I elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip can generate an idea that “explodes” in the mind, I know it’s going to do very well in boosting sales tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Are You Getting Sucked Back Out To Sea? How To Get Your Medical Staffing Going And Growing Using a Sales Process - Wins & Results
|